rs5977910
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001164617.2(GPC3):c.338-13090T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.97 ( 36604 hom., 31756 hem., cov: 23)
Failed GnomAD Quality Control
Consequence
GPC3
NM_001164617.2 intron
NM_001164617.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.894
Publications
1 publications found
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
- Simpson-Golabi-Behmel syndromeInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Simpson-Golabi-Behmel syndrome type 1Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001164617.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GPC3 | NM_004484.4 | MANE Select | c.338-13090T>G | intron | N/A | NP_004475.1 | |||
| GPC3 | NM_001164617.2 | c.338-13090T>G | intron | N/A | NP_001158089.1 | ||||
| GPC3 | NM_001164618.2 | c.290-13090T>G | intron | N/A | NP_001158090.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GPC3 | ENST00000370818.8 | TSL:1 MANE Select | c.338-13090T>G | intron | N/A | ENSP00000359854.3 | |||
| GPC3 | ENST00000394299.7 | TSL:1 | c.338-13090T>G | intron | N/A | ENSP00000377836.2 | |||
| GPC3 | ENST00000631057.2 | TSL:1 | c.176-13090T>G | intron | N/A | ENSP00000486325.1 |
Frequencies
GnomAD3 genomes AF: 0.967 AC: 107121AN: 110829Hom.: 36613 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
107121
AN:
110829
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.966 AC: 107164AN: 110880Hom.: 36604 Cov.: 23 AF XY: 0.961 AC XY: 31756AN XY: 33056 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
107164
AN:
110880
Hom.:
Cov.:
23
AF XY:
AC XY:
31756
AN XY:
33056
show subpopulations
African (AFR)
AF:
AC:
30327
AN:
30526
American (AMR)
AF:
AC:
10183
AN:
10381
Ashkenazi Jewish (ASJ)
AF:
AC:
2584
AN:
2640
East Asian (EAS)
AF:
AC:
2758
AN:
3523
South Asian (SAS)
AF:
AC:
2136
AN:
2553
European-Finnish (FIN)
AF:
AC:
5354
AN:
5842
Middle Eastern (MID)
AF:
AC:
215
AN:
217
European-Non Finnish (NFE)
AF:
AC:
51504
AN:
53020
Other (OTH)
AF:
AC:
1451
AN:
1499
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
116
233
349
466
582
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.